Categories:
North Dakota Medicaid Drug Use Review Board
Wednesday, Sept. 6, 2023
1 to 4 p.m. Central Time
In-Person Information
Conference Room 210/212, 2nd Floor, Judicial Wing, State Capitol
600 E. Boulevard Ave., Bismarck
Virtual Information
Join virtually: Click here to join the meeting
Join by phone: 701-328-0950, Conference ID: 617 220 993#
Agenda
Call to Order
Roll Call
Review and Approval of Minutes
Reports from Department
- Administrative Report: Unwinding
- Financial Report: Budget, Top Drugs
- Clinical Report: Prior authorization update, Criteria update
- RSV season and new products update
- Humira biosimilars update
- Update to Gout
- Update to Chronic Kidney Disease
- Update to Long-Acting Opioid Analgesics
- Update to Opioid Use Disorder
- Update to Clostridioides difficile-associated diarrhea (CDAD)
- Update to Medications over $3000
- Retrospective DUR report
Unfinished Business
- Update to Hyperparathyroidism (Sensipar)
New business
- First Review of Diuretics (triamterene)
- First Review of Menopause (Veozah)
- Review of retrospective DUR criteria recommendations
Announcements
- Next Meeting (December 6th, 2023)
Adjourn
Individuals with disabilities who need accommodations, including appropriate auxiliary aids to participate, can contact Ashley Gerving at 701-328-2354, toll-free 800-755-2604, 711 (TTY) or gervingashley@nd.gov.
Date Posted: Jan. 31, 2023
Date Revised: Aug. 4, 2023 (agenda/meeting details added)